Efficacy and safety of dulaglutide monotherapy compared with glimepiride in East-Asian patients with type 2 diabetes in a multicentre, double-blind, randomized, parallel-arm, active comparator, phase III trial

Yu Hong Chen; Chien-Ning Huang; Young Min Cho; Pengfei Li; Liqun Gu; Feng Wang; Jun Yang; Wei Qing Wang

doi:10.1111/dom.13340

Efficacy and safety of dulaglutide monotherapy compared with glimepiride in East-Asian patients with type 2 diabetes in a multicentre, double-blind, randomized, parallel-arm, active comparator, phase III trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.13340 ◽

2018 ◽

Vol 20 (9) ◽

pp. 2121-2130 ◽

Cited By ~ 14

Author(s):

Yu Hong Chen ◽

Chien-Ning Huang ◽

Young Min Cho ◽

Pengfei Li ◽

Liqun Gu ◽

...

Keyword(s):

Type 2 Diabetes ◽

East Asian ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Phase Iii Trial ◽

Active Comparator ◽

Asian Patients ◽

East Asian Patients

Download Full-text

Efficacy and safety of teneligliptin, a novel dipeptidyl peptidase-4 inhibitor, in Korean patients with type 2 diabetes mellitus: a 24-week multicentre, randomized, double-blind, placebo-controlled phase III trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.12631 ◽

2016 ◽

Vol 18 (5) ◽

pp. 528-532 ◽

Cited By ~ 12

Author(s):

S. Hong ◽

C.-Y. Park ◽

K. A. Han ◽

C. H. Chung ◽

B. J. Ku ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Phase Iii Trial ◽

Double Blind Placebo ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor

Download Full-text

Efficacy and Safety of Once Weekly Dulaglutide in East Asian Patients with Type 2 Diabetes: Subgroup Analysis by Potential Influential Factors

Diabetes Therapy ◽

10.1007/s13300-020-00955-2 ◽

2020 ◽

Author(s):

Jianhua Ma ◽

Bin Zhang ◽

Jianing Hou ◽

Yongde Peng

Keyword(s):

Type 2 Diabetes ◽

Subgroup Analysis ◽

East Asian ◽

Influential Factors ◽

Efficacy And Safety ◽

Asian Patients ◽

East Asian Patients

Download Full-text

Efficacy and Safety of Cisplatin/Pemetrexed Versus Cisplatin/Gemcitabine as First-Line Treatment in East Asian Patients with Advanced Non-small Cell Lung Cancer: Results of an Exploratory Subgroup Analysis of a Phase III Trial

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e3181d1273d ◽

2010 ◽

Vol 5 (5) ◽

pp. 688-695 ◽

Cited By ~ 35

Author(s):

Chih-Hsin Yang ◽

Lorinda Simms ◽

Keunchil Park ◽

Jin Soo Lee ◽

Giorgio Scagliotti ◽

...

Keyword(s):

East Asian ◽

Small Cell ◽

Phase Iii ◽

Efficacy And Safety ◽

Small Cell Lung ◽

First Line ◽

Phase Iii Trial ◽

Asian Patients ◽

First Line Treatment ◽

East Asian Patients

Download Full-text

Comparison of efficacy and safety of two starting insulin regimens in non-Asian, Asian Indian, and East Asian patients with type 2 diabetes: a post hoc analysis of the PARADIGM study

Diabetes Metabolic Syndrome and Obesity Targets and Therapy ◽

10.2147/dmso.s104752 ◽

2016 ◽

Vol Volume 9 ◽

pp. 243-249 ◽

Cited By ~ 12

Author(s):

Thomas Lew ◽

Linong JI ◽

Kyung Wan MIN ◽

Juliana Oliveira ◽

Ran DUAN

Keyword(s):

Type 2 Diabetes ◽

Asian Indian ◽

East Asian ◽

Efficacy And Safety ◽

Post Hoc Analysis ◽

Asian Patients ◽

Post Hoc ◽

East Asian Patients

Download Full-text

Efficacy and safety of fasiglifam ( TAK ‐875), a G protein‐coupled receptor 40 agonist, in J apanese patients with type 2 diabetes inadequately controlled by diet and exercise: a randomized, double‐blind, placebo‐controlled, phase III trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.12467 ◽

2015 ◽

Vol 17 (7) ◽

pp. 675-681 ◽

Cited By ~ 78

Author(s):

K. Kaku ◽

K. Enya ◽

R. Nakaya ◽

T. Ohira ◽

R. Matsuno

Keyword(s):

Type 2 Diabetes ◽

G Protein ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Phase Iii Trial ◽

Double Blind Placebo ◽

Diet And Exercise ◽

G Protein Coupled

Download Full-text

Efficacy and safety of paliperidone palmitate three-monthly formulation in East Asian patients with schizophrenia: subgroup analysis of a global, randomized, double-blind, Phase III, noninferiority study

Neuropsychiatric Disease and Treatment ◽

10.2147/ndt.s134287 ◽

2017 ◽

Vol Volume 13 ◽

pp. 2193-2207 ◽

Cited By ~ 3

Author(s):

Adam Savitz ◽

Haiyan Xu ◽

Srihari Gopal ◽

Isaac Nuamah ◽

Paulien Ravenstijn ◽

...

Keyword(s):

Subgroup Analysis ◽

East Asian ◽

Phase Iii ◽

Paliperidone Palmitate ◽

Efficacy And Safety ◽

Double Blind ◽

Asian Patients ◽

East Asian Patients

Download Full-text

Efficacy and safety of once-weekly dulaglutide versus insulin glargine in mainly Asian patients with type 2 diabetes mellitus on metformin and/or a sulphonylurea: A 52-week open-label, randomized phase III trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.13506 ◽

2018 ◽

Vol 21 (2) ◽

pp. 234-243 ◽

Cited By ~ 16

Author(s):

Weiqing Wang ◽

Luis Nevárez ◽

Ekaterina Filippova ◽

Ki Ho Song ◽

Bei Tao ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Insulin Glargine ◽

Phase Iii ◽

Efficacy And Safety ◽

Open Label ◽

Phase Iii Trial ◽

Asian Patients

Download Full-text

Efficacy and safety of teneligliptin, a dipeptidyl peptidase‐4 inhibitor, combined with metformin in K orean patients with type 2 diabetes mellitus: a 16‐week, randomized, double‐blind, placebo‐controlled phase III trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.12424 ◽

2015 ◽

Vol 17 (3) ◽

pp. 309-312 ◽

Cited By ~ 22

Author(s):

M. K. Kim ◽

E.‐J. Rhee ◽

K. A. Han ◽

A. C. Woo ◽

M.‐K. Lee ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Phase Iii Trial ◽

Double Blind Placebo ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor

Download Full-text

Long-Term Efficacy and Safety of Empagliflozin Monotherapy in Drug-Naïve Patients with Type 2 Diabetes in Indian Subgroup: Results from a 76-week Extension Trial of Phase III, Double-Blind, Randomized Study

Indian Journal of Endocrinology and Metabolism ◽

10.4103/ijem.ijem_517_16 ◽

2017 ◽

Vol 21 (2) ◽

pp. 286 ◽

Cited By ~ 8

Author(s):

Viraj Suvarna ◽

Sunil Gupta ◽

Shehla Shaikh ◽

Pooja Joshi ◽

Shraddha Bhure

Keyword(s):

Type 2 Diabetes ◽

Randomized Study ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Term Efficacy ◽

Drug Naïve ◽

Extension Trial

Download Full-text

Safety and Tolerability of Empagliflozin in East Asian Patients with Type 2 Diabetes—Pooled Analysis of Phase I-III Clinical Trials

Diabetes ◽

10.2337/db18-1150-p ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 1150-P

Author(s):

ATSUTAKA YASUI ◽

DAISUKE YABE ◽

LINONG JI ◽

MOON-KYU LEE ◽

RONALD C. MA ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trials ◽

Phase I ◽

East Asian ◽

Pooled Analysis ◽

Asian Patients ◽

East Asian Patients

Download Full-text